Daniel, I disagree. You discovered a company on death's door and through your Remarkable due diligence, you saw a way to perhaps fix its problems and direction.. Investors aren’t supposed to spot AND fix fatally flawed companies; they are simply required to spot companies compelling enough to invest in.
you went through the entire pile of Australian biotechs and rejected virtually all of them as being too risky to invest in!
australian biotechs like to say they are world-standard, but where is the evidence of Their blow-me-out-of-water commercial success? Or even an awesome buyout!
RAC - Charts & Price Action, page-309
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
-0.055(3.77%) |
Mkt cap ! $236.2M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.40 | $157.9K | 111.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3980 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.41 | 2613 | 2 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.40 |
Change
-0.055 ( 2.23 %) |
||||
| Open | High | Low | Volume | ||
| $1.44 | $1.44 | $1.40 | 6146 | ||
| Last updated 15.46pm 28/05/2024 ? | |||||
| RAC (ASX) Chart |